OncoCyte IMDX
Oncocyte Reports Second Quarter 2021 Financial Results and Provides Corporate Update
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001493152-21-019204
- Document
- 8-K
- Exhibit 99.1
- Press release
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2835) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.
- Immucell ICCC public float $51M, Jun 30, 2025
- Alpha Teknova TKNO public float $54M, Jun 30, 2025
- Biomerica BMRA public float $7M, Nov 28, 2025
- Cardio Diagnostics Holdings CDIO public float $6M, Jun 30, 2025
- Aspira Women's Health AWHL public float $5M, Jun 30, 2025
